Simple keyword search and advanced search
close
or

NSW Health / Pharmaceuticals - Supplementary - Pre Notice - NOTICE - HSBP_HC15_902_S1

RFT ID NOTICE - HSBP_HC15_902_S1
RFT Type Notice
Published 24-Jul-2018
Closes 31-Aug-2018 11:45pm
Category Drugs and Pharmaceutical Products
Agency HealthShare NSW


Contact Person
Michael Miller
Phone: 02 8644 2054
michael.miller@health.nsw.gov.au

Tender Details

The current ‘902’ contract lists approximately 2500 pharmaceutical product categories by generic name, form and strength. 

The focus of the supplementary tender will be a small number of products (up to approximately 50 product categories) which have not previously been awarded on contract 902, including previously unidentified product categories.

Responses may also be sought for product categories already awarded on the panel, with a view to add new products within those existing product categories, though very few (if any) products are likely to be included in this activity.

Location

NSW Regions: Far North Coast, Mid North Coast, New England, Central Coast, Hunter, Cumberland/Prospect, Nepean, Northern Sydney, Inner West, South East Sydney, South West Sydney, Central West, Orana/Far West, Riverina/Murray, Illawarra, Southern Highlands
States and Territories: ACT

Estimated Value

From $60,000,000.00 to $180,000,000.00

RFT Type

Notice - A notice published on this website that relates to procurement or other relevant matters. It does not normally require any formal response. This is not a tender.

This tender opportunity is not expected to lead to the award of a contract. This is a pre notice of an upcoming supplementary tender. Further details to be published with release of tender documents.


Related Records


Additional Details / Instructions

Anticipated release date in August 2018.

Address for Lodgement

Pre Notice Only. No response required.

Conditions for Participation

Pre Notice Only. No response required.

Estimated Timeframe for Delivery

Notice of upcoming activity, planned for August 2018.


Multi Agency Access

Yes

Multi Agency Access Type

All Agencies